{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:40:07Z","timestamp":1785814807551,"version":"3.56.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.molmet.2024.102002","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:15:18Z","timestamp":1722903318000},"page":"102002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Bitter-tasting drugs tune GDF15 and GLP-1 expression via bitter taste or motilin receptors in the intestine of patients with obesity"],"prefix":"10.1016","volume":"88","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Farhadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ruilova Sosoranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Van der Schueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens J.","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Deleus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lannoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-2175","authenticated-orcid":false,"given":"Inge","family":"Depoortere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.molmet.2024.102002_bib1","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.molmet.2024.102002_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.humimm.2021.06.007","article-title":"Roles and regulation of growth differentiation factor-15 in the immune and tumor microenvironment","volume":"82","author":"Silviya Lodi","year":"2021","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.molmet.2024.102002_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jcmm.17725","article-title":"Overview of growth differentiation factor 15 in metabolic syndrome","volume":"27","author":"Asrih","year":"2023","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14728222.2022.2029410","article-title":"GDF15: a potential therapeutic target for type 1 diabetes","volume":"26","author":"Sarkar","year":"2022","journal-title":"Expert Opin Ther\u00a0Targets"},{"issue":"5","key":"10.1016\/j.molmet.2024.102002_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3892\/ol.2023.14049","article-title":"Role of growth differentiation factor 15 in cancer cachexia","volume":"26","author":"Ling","year":"2023","journal-title":"Oncol Lett"},{"issue":"412","key":"10.1016\/j.molmet.2024.102002_bib7","doi-asserted-by":"crossref","first-page":"eaan8732","DOI":"10.1126\/scitranslmed.aan8732","article-title":"Long-acting MIC-1\/GDF15 molecules to treat obesity: evidence from mice to monkeys","volume":"9","author":"Xiong","year":"2017","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.molmet.2024.102002_bib8","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15\u2013GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.molmet.2024.102002_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2022.12.011","article-title":"Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist","volume":"35","author":"Benichou","year":"2023","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.molmet.2024.102002_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"issue":"7675","key":"10.1016\/j.molmet.2024.102002_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","article-title":"GDF15 induces anorexia through nausea and emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Metab"},{"issue":"D1","key":"10.1016\/j.molmet.2024.102002_bib14","doi-asserted-by":"crossref","first-page":"D1179","DOI":"10.1093\/nar\/gky974","article-title":"BitterDB: taste ligands and receptors database in 2019","volume":"47","author":"Dagan-Wiener","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"7795","key":"10.1016\/j.molmet.2024.102002_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/23.3.425","article-title":"Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53","volume":"23","author":"Baek","year":"2002","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.molmet.2024.102002_bib17","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/oby.21523","article-title":"Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: a randomized controlled trial","volume":"24","author":"Arzola-Paniagua","year":"2016","journal-title":"Obesity"},{"issue":"12","key":"10.1016\/j.molmet.2024.102002_bib18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","article-title":"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss","volume":"1","author":"Day","year":"2019","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.molmet.2024.102002_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80705-9","article-title":"A\u00a0novel family of mammalian taste receptors","volume":"100","author":"Adler","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/emph\/eoab031","article-title":"Bitter taste receptors: genes, evolution, and health","volume":"9","author":"Wooding","year":"2021","journal-title":"Evol Med Public Health"},{"issue":"12","key":"10.1016\/j.molmet.2024.102002_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145538","article-title":"The gustatory signaling pathway and bitter taste receptors affect the development of obesity and adipocyte metabolism in mice","volume":"10","author":"Avau","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2024.102002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170284","article-title":"Extra-oral bitter taste receptors: new targets against obesity?","volume":"127","author":"Wang","year":"2020","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.molmet.2024.102002_bib23","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1096\/fj.201801661RR","article-title":"Obesity alters adrenergic and chemosensory signaling pathways that regulate ghrelin secretion in the human gut","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.molmet.2024.102002_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmet.2018.07.013","article-title":"Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits","volume":"16","author":"Kok","year":"2018","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13171","article-title":"Intragastric infusion of the bitter tastant quinine suppresses hormone release and antral motility during the fasting state in healthy female volunteers","volume":"30","author":"Deloose","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3945\/ajcn.116.138297","article-title":"Intragastric infusion of denatonium benzoate attenuates interdigestive gastric motility and hunger scores in healthy female volunteers","volume":"105","author":"Deloose","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib27","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1152\/ajpregu.00294.2019","article-title":"Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men","volume":"318","author":"Bitarafan","year":"2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"12","key":"10.1016\/j.molmet.2024.102002_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/1028415X.2018.1457841","article-title":"Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms","volume":"22","author":"Iven","year":"2018","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.molmet.2024.102002_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep15985","article-title":"Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation","volume":"5","author":"Avau","year":"2015","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.molmet.2024.102002_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cpdd.1100","article-title":"First-in-human evaluation of oral denatonium acetate (ARD-101), a potential bitter taste receptor agonist: a randomized, double-blind, placebo-controlled phase 1 trial in healthy adults","volume":"11","author":"Niethammer","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.molmet.2024.102002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101117","article-title":"Growth differentiation factor 15 as a potential therapeutic for treating obesity","volume":"46","author":"Hale","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/chemse\/bjp092","article-title":"The molecular receptive ranges of human TAS2R bitter taste receptors","volume":"35","author":"Meyerhof","year":"2009","journal-title":"Chem Senses"},{"issue":"7","key":"10.1016\/j.molmet.2024.102002_bib33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/acsinfecdis.8b00094","article-title":"Characterization of the binding sites for bacterial acyl homoserine lactones (AHLs) on human bitter taste receptors (T2Rs)","volume":"4","author":"Jaggupilli","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1096\/fj.201800521RR","article-title":"Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics","volume":"33","author":"Jaggupilli","year":"2018","journal-title":"FASEB J"},{"issue":"44","key":"10.1016\/j.molmet.2024.102002_bib35","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1021\/jf403387p","article-title":"Bitter taste receptor activation by flavonoids and isoflavonoids: modeled structural requirements for activation of hTAS2R14 and hTAS2R39","volume":"61","author":"Roland","year":"2013","journal-title":"J\u00a0Agric Food Chem"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib36","first-page":"45","article-title":"BitterMatch: recommendation systems for matching molecules with bitter taste receptors","volume":"14","author":"Margulis","year":"2022","journal-title":"J\u00a0Cheminf"},{"issue":"36","key":"10.1016\/j.molmet.2024.102002_bib37","doi-asserted-by":"crossref","first-page":"10550","DOI":"10.1021\/acs.jafc.1c03061","article-title":"Astringent gallic acid in red wine regulates mechanisms of gastric acid secretion via activation of bitter taste sensing receptor TAS2R4","volume":"69","author":"Sterneder","year":"2021","journal-title":"J\u00a0Agric Food Chem"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1096\/fj.13-242594","article-title":"The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14","volume":"28","author":"Levit","year":"2013","journal-title":"FASEB J"},{"issue":"29","key":"10.1016\/j.molmet.2024.102002_bib39","doi-asserted-by":"crossref","first-page":"15358","DOI":"10.1074\/jbc.M116.718544","article-title":"Comprehensive analysis of mouse bitter taste receptors reveals different molecular receptive ranges for orthologous receptors in mice and humans","volume":"291","author":"Lossow","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"D1","key":"10.1016\/j.molmet.2024.102002_bib40","doi-asserted-by":"crossref","first-page":"D413","DOI":"10.1093\/nar\/gkr755","article-title":"BitterDB: a database of bitter compounds","volume":"40","author":"Wiener","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.molmet.2024.102002_bib41","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cub.2010.04.043","article-title":"Modulation of bitter taste perception by a small molecule hTAS2R antagonist","volume":"20","author":"Slack","year":"2010","journal-title":"Curr Biol"},{"key":"10.1016\/j.molmet.2024.102002_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.952299","article-title":"Global population genetics and diversity in the TAS2R bitter taste receptor family","volume":"13","author":"Wooding","year":"2022","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12263-014-0401-y","article-title":"Genetic signature of differential sensitivity to stevioside in the Italian population","volume":"9","author":"Risso","year":"2014","journal-title":"Genes Nutr"},{"issue":"16","key":"10.1016\/j.molmet.2024.102002_bib44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cub.2007.07.046","article-title":"Specific alleles of bitter receptor genes influence human sensitivity to the bitterness of aloin and saccharin","volume":"17","author":"Pronin","year":"2007","journal-title":"Curr Biol"},{"issue":"8","key":"10.1016\/j.molmet.2024.102002_bib45","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/bph.12077","article-title":"The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin","volume":"168","author":"Broad","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.molmet.2024.102002_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2009.04.059","article-title":"An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying","volume":"615","author":"Ozaki","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144828","article-title":"Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity","volume":"132","author":"Liszt","year":"2022","journal-title":"J\u00a0Clin Investig"},{"issue":"7","key":"10.1016\/j.molmet.2024.102002_bib48","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1210\/clinem\/dgac182","article-title":"Quinine effects on gut and pancreatic hormones and antropyloroduodenal pressures in humans-role of delivery site and sex","volume":"107","author":"Rezaie","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib49","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00636.2020","article-title":"The endocrine effects of bitter tastant administration in the gastrointestinal system: intragastric versus intraduodenal administration","volume":"321","author":"Verbeure","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.molmet.2024.102002_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.tem.2021.08.008","article-title":"Stress-induced FGF21 and GDF15 in obesity and obesity resistance","volume":"32","author":"Keipert","year":"2021","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.molmet.2024.102002_bib51","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.2200641","article-title":"Emerging roles of growth differentiation factor 15 in immunoregulation and pathogenesis","volume":"210","author":"Reyes","year":"2023","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.molmet.2024.102002_bib53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/bph.16278","article-title":"Newer pharmacological interventions directed at gut hormones for obesity","volume":"181","author":"Camilleri","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.molmet.2024.102002_bib54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/dom.14663","article-title":"Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms","volume":"24","author":"Ghidewon","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2024.102002_bib55","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.2608-23","article-title":"Hot water eliminates the bitter taste of oral semaglutide: a report of four cases","author":"Okada","year":"2024","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib56","first-page":"112","article-title":"Taste masking and molecular properties of metformin hydrochloride-indion 234 complexes","volume":"3","author":"Bhoyar","year":"2011","journal-title":"J\u00a0Young Pharm"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 provides an endocrine signal of nutritional stress in mice and humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.molmet.2024.102002_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.molmet.2024.102002_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2015","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cancers13010099","article-title":"Association between growth differentiation factor-15 (GDF-15) serum levels, anorexia and low muscle mass among cancer patients","volume":"13","author":"Alessio","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib61","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/jcsm.13435","article-title":"Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design","volume":"15","author":"Groarke","year":"2024","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"7996","key":"10.1016\/j.molmet.2024.102002_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 linked to maternal risk of nausea and vomiting during pregnancy","volume":"625","author":"Fejzo","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib63","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s42003-023-04965-1","article-title":"Stress-responsive Gdf15 counteracts renointestinal toxicity via autophagic and microbiota reprogramming","volume":"6","author":"Ray","year":"2023","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.molmet.2024.102002_bib64","doi-asserted-by":"crossref","first-page":"G470","DOI":"10.1152\/ajpgi.1989.257.3.G470","article-title":"Erythromycin is a motilin receptor agonist","volume":"257","author":"Peeters","year":"1989","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5423","key":"10.1016\/j.molmet.2024.102002_bib65","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1126\/science.284.5423.2184","article-title":"Receptor for motilin identified in the human gastrointestinal system","volume":"284","author":"Feighner","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.molmet.2024.102002_bib66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41574-019-0155-0","article-title":"Motilin: from gastric motility stimulation to hunger signalling","volume":"15","author":"Deloose","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"15","key":"10.1016\/j.molmet.2024.102002_bib67","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM199004123221502","article-title":"Improvement of gastric emptying in diabetic gastroparesis by erythromycin","volume":"322","author":"Janssens","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.102002_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01300701","article-title":"Erythromycin induces migrating motor complex in human gastrointestinal tract","volume":"31","author":"Tomomasa","year":"1986","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.molmet.2024.102002_bib69","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0016-5085(91)90383-V","article-title":"Gastrointestinal motor effects of erythromycin in humans","volume":"101","author":"Sarna","year":"1991","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/106002808902300108","article-title":"Intravenous erythromycin lactobionate-induced severe nausea and vomiting","volume":"23","author":"Seifert","year":"1989","journal-title":"DICP"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-199920010-00004","article-title":"Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients","volume":"20","author":"Principi","year":"1999","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/014860710803200145","article-title":"Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition","volume":"32","author":"Landzinski","year":"2008","journal-title":"J\u00a0Parenter Enteral Nutr"},{"issue":"1","key":"10.1016\/j.molmet.2024.102002_bib73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13054-016-1441-z","article-title":"The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials","volume":"20","author":"Lewis","year":"2016","journal-title":"Crit Care"},{"issue":"13","key":"10.1016\/j.molmet.2024.102002_bib74","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1304623","article-title":"Nutrition in the acute phase of critical illness","volume":"370","author":"Casaer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.molmet.2024.102002_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0031-9384(94)90361-1","article-title":"PTC\/PROP tasting: anatomy, psychophysics, and sex effects","volume":"56","author":"Bartoshuk","year":"1994","journal-title":"Physiol Behav"},{"issue":"19","key":"10.1016\/j.molmet.2024.102002_bib76","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.3390\/nu15194264","article-title":"The acute effect of hydroxychloroquine sulfate on hunger, the plasma concentration of orexigenic peptides and hedonic food intake: a pilot study","volume":"15","author":"Ruilova Sosoranga","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.molmet.2024.102002_bib77","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat Protoc"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T09:18:47Z","timestamp":1726391927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":77,"alternative-id":["S2212877824001339"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.102002","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bitter-tasting drugs tune GDF15 and GLP-1 expression via bitter taste or motilin receptors in the intestine of patients with obesity","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.102002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102002"}}